Study of VELCADE and Rituximab in Patients With Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma

NCT00312845 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

676

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-Hodgkin's Lymphoma

Interventions

DRUG: Bortezomib + Rituximab
DRUG: Rituximab

Sponsor

Millennium Pharmaceuticals, Inc.

Collaborators

[object Object]